期刊文献+

奥美拉唑联合用药致心前区疼痛1例用药分析 被引量:1

Analysis on One Case of Percardial Pain Induced by Drug Combination of Omeprazole
原文传递
导出
摘要 目的:为临床联合用药提供参考。方法:通过对2009年12月2日以"高血压病3级、冠心病、慢性支气管炎急性发作"收治的1名79岁男性患者,在应用注射用奥美拉唑钠治疗过程中心前区疼痛的观察和治疗,提出临床应用奥美拉唑出现的不良反应及应对措施。结果与结论:奥美拉唑与其它药物联用易引起心前区疼痛的不良反应。因样本有限,普遍性有待进一步证实。 OBJECTIVE:To analyze one case of pericardial pain induced by drug combination of omeprazole so as to provide reference for drug combination in the clinic. METHODS:A 79-year-old male patient was admitted because of stage Ⅲ hypertension,coronary heart disease,acute attack of chronic bronchitis in Dec. 2 of 2009. He was treated with omeprazole and pericardial pain was observed during treatment. ADR caused by omeprazole were put forward in the clinic. RESULTS CONCLUSION: Omeprazole combined with other drugs can easily cause ADR for example,pericardial pain. The universality of ADR induced by drug combination of omeprazole should be further confirmed because of limited sample.
机构地区 解放军第
出处 《中国药房》 CAS CSCD 北大核心 2010年第16期1507-1508,共2页 China Pharmacy
关键词 奥美拉唑 心前区疼痛 联合用药 用药分析 Omeprazole Precordial pain Drug combination Analysis of drug use
  • 相关文献

参考文献6

二级参考文献77

  • 1Lilja J J, Kivisto K T, Neuvonen P J. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin [ J ]. Clin Pharmacol Ther, 1999,66 (2) :118-127.
  • 2Lilja J J,Kivisto K T,Neuvonen P J. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin[ J ]. Clin Pharmacol Ther, 2000,68 (4) :384-390.
  • 3Rogers J D, Zhao J, Liu L, et al. Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl eoenzyme A reductase inhibitors[J]. Clin Pharmacol Ther, 1999,66(4) :358-366.
  • 4Herman D, Locatelli I, Grabnar I, et al. The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose [ J ]. Eur J Clin Pharmacol,2006,62(4) :291-296.
  • 5Lin J C, Ito M K. A drug interaction between troglitazone and simvastatin. Diabetes [ J ]. Care, 1999, 22 ( 12 ) : 2104-2106.
  • 6Shitara Y, Sugiyama Y. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions [ J ]. Pharmacol Ther, 2006, 112(1) :71-105.
  • 7Boyd R A, Stern R H, Stewart B H, et al. Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal Pglycoprotein-mediated secretion [J]. J Clin Pharmacol,2000 ,40(1) :91-98.
  • 8Gamett W R, Venitz J, Wilkens R C, et al. Pharmacokinetic effects of fluvastatin in patients chronically receiving digoxin[ J]. Am J Med,1994 ,96( 6A ) :845-865.
  • 9Alsheikh-Ali A A,Kuvin J T,Karas R H. Risk of adverse events with fibrates[J]. Am J Cardiol,2004,94(7) :935- 938.
  • 10Tficor (fenofibrate) tablets [ EB/OL]. North Chicago: Abbott laboratories ,2007 [ 2008-08-02 ]. http ://www. tricortablets.com/tricor/hcp/indications_pi. jsp.

共引文献50

同被引文献9

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部